ReviewCancer drug resistance (Alhambra, Calif.)2022

Association between genome-wide epigenetic and genetic alterations in breast cancer tissue and response to HER2-targeted therapies in HER2-positive breast cancer patients: new findings and a systematic review.

Daniela Furrer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.